US authorities are examining the Hepatitis B vaccine for newborns
- Last update: 1 days ago
- 2 min read
- 440 Views
- POLITICS
Health experts appointed by the Trump-era Health Secretary Robert F. Kennedy Jr., known for his vaccine skepticism, are set to evaluate the administration of hepatitis B vaccines to newborns this Thursday. The review may consider postponing the shots despite widespread opposition from medical professionals.
The newly formed Advisory Committee on Immunization Practices (ACIP) will meet for two days in Atlanta, Georgia, following up on recommendations made in September regarding Covid-19 and measles vaccinations. Under Kennedy's leadership, ACIP has launched a broad safety review of multiple long-established vaccines, raising concern within the medical and scientific community.
Medical specialists warn that changes in vaccination policies could lead to declining immunization rates and the resurgence of dangerous diseases such as measles, which claimed lives in 2025. Infectious disease and pediatric expert Sean O'Leary criticized the committee, stating that any modifications would likely be driven by ideology rather than scientific evidence.
Since 1991, US guidelines have recommended hepatitis B vaccination for newborns, as the infection can cause chronic liver disease, cirrhosis, or liver cancer. O'Leary emphasized the stakes: "Ninety percent of babies infected with hepatitis B develop chronic liver disease, and a quarter of them may die from the infection. These deaths are preventable."
Opposition to the vaccine has come from anti-vaccine groups and former President Donald Trump, who suggested in September that children should not receive the hepatitis B vaccine until age 12, arguing that the disease is sexually transmitted. Health professionals counter that newborns can contract the virus from their mothers during pregnancy or childbirth, and delaying vaccination could reduce overall coverage due to inconsistent healthcare access.
Recent research from the University of Minnesota analyzed over 400 studies and found no benefit to postponing the hepatitis B vaccine, highlighting significant risks if current US guidelines were altered.
The ACIP's recommendations have significant implications, as federal vaccine guidelines influence insurance coverage for vaccines in the United States, where medical costs for childbirth and vaccinations can be substantial. However, the committees authority is increasingly challenged, with several Democratic-led states forming independent advisory panels in response to skepticism about Kennedys leadership.
Pediatrician Paul Offit commented on the situation: "States are creating their own advisory committees because they don't trust anything under Robert F. Kennedy Jr., who is an anti-vaccine activist and science denialist. People following ACIP meetings brace themselves for potentially harmful recommendations."
Author: Olivia Parker
Share
CDC panel to decide on hepatitis B vaccination for infants
1 days ago 3 min read POLITICS
Kennedy's vaccine advisors to consider timing of hepatitis B vaccine in significant policy shift
1 days ago 3 min read POLITICS
Kennedy's selected CDC advisors to consider significant alteration to childhood vaccine schedule
1 days ago 4 min read HEALTH
Twelve ex-Commissioners of the US FDA express grave concerns over agency's vaccine policy shift, according to NEJM
1 days ago 2 min read BUSINESS
Twelve former FDA leaders criticize current FDA vaccine chief's claims
1 days ago 2 min read POLITICS
Former FDA commissioners criticize Trump administration's vaccine plan
1 days ago 2 min read POLITICS
12 former FDA officials criticize statements made by current vaccine chief
1 days ago 3 min read HEALTH
RFK Jr.'s panel may soon change the hepatitis B vaccine. What you should be aware of
1 days ago 4 min read POLITICS
Understanding the hepatitis B vaccine and the reasons behind Trump officials targeting it
1 days ago 3 min read POLITICS
Understanding the hepatitis B vaccination and the reasons behind Trump officials' focus on it
1 days ago 4 min read POLITICS